White paperThe Enterprise Framework for Compliant, Scalable AI
Download now

Third-Party Risk Management for Life Sciences

A practical guide to third-party risk management (TPRM) for life sciences: how to assess vendors, prove compliance with 21 CFR Part 11, ISO 27001, NIST, and GxP, and protect critical data across your vendor ecosystem.

Third-Party Risk Management for Life Sciences

The Short Version

Life sciences companies run on a deep network of third-party vendors, and every one of them is a potential cybersecurity, financial, and compliance exposure. A disciplined third-party risk management (TPRM) program turns that ecosystem from a blind spot into a governed, auditable asset. This article covers the business outcomes a strong TPRM program delivers, the regulatory frameworks it has to satisfy, and how USDM helps biotech, pharma, and medical device organizations build a secure and resilient vendor ecosystem.

Safeguard Your Vendor Ecosystem and Achieve Compliance with Confidence

In an industry where data integrity, patient safety, and regulatory compliance are non-negotiable, life sciences organizations depend on an extensive network of third-party vendors. Yet, every vendor introduces potential cybersecurity vulnerabilities, financial risks, and compliance challenges.

USDM’s Third-Party Risk Management (TPRM) solutions provide automated risk assessments, real-time monitoring, and actionable insights to ensure your vendors align with HIPAA, GDPR, 21 CFR Part 11, ISO 27001, and other life sciences regulations. When vendor data feeds GxP systems, that same scrutiny is what keeps your data integrity defensible under inspection.

Why this matters now: Regulators increasingly expect you to own the risk of your suppliers, not just your own systems. An auditor will not accept “that was the vendor’s responsibility” when a third party touches GxP data, patient information, or validated systems. TPRM is how you make that ownership demonstrable.

Business Outcomes That Drive Success

Reduced Cybersecurity Risks

  • Identify, assess, and mitigate third-party vulnerabilities before they impact your business.
  • Enhance resilience against data breaches, ransomware attacks, and operational disruptions through proactive vendor monitoring.
  • Leverage continuous threat intelligence to stay ahead of emerging risks.

Vendor risk does not live in isolation — it is one layer of a broader security posture. USDM positions TPRM alongside its life sciences cybersecurity services so that vendor findings flow into the same program that protects your internal systems.

Streamlined Compliance and Regulatory Readiness

  • Automate compliance assessments with 14+ regulatory frameworks, including NIST, ISO 27001, and GxP requirements.
  • Ensure audit readiness and avoid costly regulatory penalties.
  • Generate real-time vendor compliance reports for simplified risk management.

For vendors that touch electronic records and signatures, that compliance work has to map cleanly to 21 CFR Part 11 expectations — the same discipline that governs how regulated electronic data is captured, protected, and attributed.

Improved Vendor Accountability

  • Implement a centralized vendor risk platform to track and enforce security measures.
  • Quantify financial risk exposure using FAIR methodology, helping stakeholders make data-driven decisions.
  • Gain full visibility into your third-party ecosystem and proactively address hidden risks.

You cannot manage the risk of a vendor you cannot see. Centralized visibility, not a spreadsheet of last year’s questionnaires, is the difference between knowing your exposure and discovering it during an audit.

Enhanced Operational Resilience

  • Protect critical supply chain and clinical data from disruptions caused by vendor cybersecurity incidents.
  • Ensure business continuity with a resilient risk management strategy that prioritizes high-impact vendors.
  • Optimize vendor selection with security-first decision-making.

A Lifecycle View of Third-Party Risk

Strong TPRM is not a one-time questionnaire — it is a continuous lifecycle that mirrors how you already manage validated systems:

  1. Identify and tier — inventory every vendor and rank them by the criticality of the data and systems they touch.
  2. Assess — evaluate each vendor against the frameworks that apply (NIST, ISO 27001, 21 CFR Part 11, GxP).
  3. Quantify — translate technical findings into financial risk exposure using FAIR methodology so leadership can prioritize.
  4. Monitor — replace point-in-time reviews with real-time monitoring and continuous threat intelligence.
  5. Remediate and report — enforce security measures and generate audit-ready vendor compliance reports on demand.

Treating vendor risk as a managed lifecycle rather than a procurement checkbox is the same mindset USDM brings to continuous compliance across your validated environment.

Download USDM's TPRM Datasheet

USDM Is the Most Trusted Partner in Life Sciences Consulting

  • Life Sciences Expertise – Decades of experience securing vendor ecosystems for biotech, pharma, and medical device companies.
  • Automated Risk Insights – AI-driven assessments that quantify cybersecurity risks and financial impact.
  • End-to-End TPRM Solutions – From licensing to fully managed services, we scale with your organization’s needs.
  • Integrated Approach – Bundle TPRM with Virtual CISO capabilities, penetration testing, and cybersecurity maturity assessments for a unified security strategy.

FAQ: Third-Party Risk Management for Life Sciences

What is third-party risk management (TPRM) in life sciences?

TPRM is the practice of identifying, assessing, monitoring, and mitigating the cybersecurity, financial, and compliance risks introduced by the external vendors a life sciences organization depends on. Because vendors often touch GxP data, patient information, and validated systems, their risk becomes the sponsor’s risk.

Which regulations and frameworks does a TPRM program need to address?

For life sciences, vendor assessments typically need to align with HIPAA, GDPR, 21 CFR Part 11, ISO 27001, NIST, and GxP requirements. USDM’s approach automates compliance assessments across 14+ regulatory frameworks so vendors can be evaluated consistently.

How does USDM quantify third-party risk?

USDM uses AI-driven assessments and the FAIR methodology to translate technical vulnerabilities into financial risk exposure, giving stakeholders a data-driven basis for prioritizing which vendors to address first.

How is TPRM different from a one-time vendor questionnaire?

A questionnaire is a point-in-time snapshot. Effective TPRM is continuous — it combines a centralized vendor risk platform, real-time monitoring, and ongoing threat intelligence so you maintain audit readiness rather than scrambling before each inspection.

Can TPRM be combined with other security services?

Yes. USDM can bundle TPRM with Virtual CISO capabilities, penetration testing, and cybersecurity maturity assessments to deliver a unified security strategy rather than a set of disconnected point solutions.

Take Control of Your Third-Party Risk Today

Let USDM help you build a secure, compliant, and resilient vendor ecosystem. Learn more about USDM’s third-party risk management offering, or contact us today to discuss how to protect your data, streamline compliance, and reduce risk across your vendors.

Watch USDM Summit 2026 On-Demand to learn more about this topic.

Ready to act on this?

Map the next practical step with USDM.

USDM can help translate the article topic into a defensible plan for your systems, teams, and regulatory context.

Explore capabilities

Find the USDM practice area most relevant to this topic.

Platform partners

See how USDM delivers outcomes on the platforms you use.

Related resources

Keep exploring

Hand-picked blogs, case studies, and guides on the same topic.

GovernanceContinuous compliance

Box Meets Complex Security and Global GxP Validation Requirements

Global biosciences company founded in China with U.S. locations, developing infectious disease treatments (including COVID-19) and in Stage II clinical trials, with limited in-house computer system validation and GxP regulatory experience.

Discover how USDM enabled FDA-ready Box GxP validation for a global biosciences company, meeting tight deadlines and complex security requirements.

Global CSV Outcome

Defensible

See proof
AI deploymentGovernance

Centralized Clinical Data Lake and Analytics

Life sciences company specializing in the development and manufacturing of acellular tissues for treating diseases, injuries, and chronic conditions, managing regulated clinical trial and biostatistics data across multiple Contract Research Organizations (CROs).

Explore how USDM implemented an AWS Clinical Data Lake to achieve 100% GxP compliance, save $500K annually, and enhance analytics reporting.

GxP Compliance

100%

See proof
Blog

Evaluating Google Agentspace for Life Sciences

A practical 10-factor framework for life sciences teams evaluating Google Agentspace—covering GxP compliance, data security, auditability, multi-agent governance, and ROI for confident, validated AI adoption.

Read
White Paper

2023 Technology Trends in Life Sciences

Explore five technology trends—automation, data collaboration platforms, cloud landing zones, AR/VR, and IoT—that help pharma, biotech, and medical device companies modernize while staying compliant. Download the white paper.

Read
Blog

How to Fulfill Expectations for Data Privacy and Security

A practical guide for life sciences teams on the tools, controls, and outsourcing decisions that protect data confidentiality, integrity, and availability while meeting GDPR, HIPAA, and CCPA expectations.

Read
Blog

When Your Clinical Trial Sites Go Dark: What the Stryker Cyberattack Means for Biotech and Pharma

What the Stryker cyberattack teaches life sciences about clinical trial site resilience — when hospital systems go dark, clinical data integrity, patient safety, and trial continuity are all at risk.

Read
Blog

Third-Party Risk Management in Life Sciences: How to Strengthen Vendor Oversight in a Regulated Industry

Learn why third-party risk management in life sciences now requires continuous monitoring, regulatory alignment, and stronger vendor governance across cyber, quality, and operational risk.

Read